(Q72563250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137940%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Clonidine-induced growth hormone secretion in chronic schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137940%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

chronic schizophrenia

1 reference

S. Lal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137940

12 August 2023

N. P. Nair

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137940

12 August 2023

J. X. Thavundayil

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137940

12 August 2023

R. C. Monks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137940

12 August 2023

H. Guyda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6137940

12 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6137940

12 August 2023

publication date

1 August 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137940%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

27 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1983.tb06985.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1983.tb06985.x/fullpdf

12 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Acta Psychiatrica Scandinavica

12 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137940%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137940%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137940%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

82-88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137940%20AND%20SRC:MED&resulttype=core&format=json

The dopamine hypothesis of schizophrenia: a review

27 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

12 August 2023

Pharmacological Reviews

2

32

229

Seeman P.

1980

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs

12 August 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

The effect of pimozide on CSF norepinephrine in schizophrenia

12 August 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

12 August 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

12 August 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Phenothiazine antagonism of the noradrenergic inhibition of cerebellar purkinje neurons

12 August 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Evidence for a central noradrenaline receptor stimulation by clonidine.

12 August 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Central α-adrenergic systems as targets for hypotensive drugs

12 August 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Binding of adrenergic ligands ([3H]clonidine and [3H]WB-4101) to multiple sites in human brain

12 August 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Effect of Clonidine on Growth Hormone, Prolactin, Luteinizing Hormone, Follicle-Stimulating Hormone, and Thyroid-Stimulating Hormone in the Serum of Normal Men

12 August 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Effect of Clonidine on Growth Hormone and Glucagon Secretion

12 August 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Effect of clonidine on growth hormone release in psychiatric patients and controls

12 August 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Growth hormone and other responses to clonidine in patients with endogenous depression

12 August 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls

12 August 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Effect of Sex, Oral Contraceptives, and Glucose Loading on Apomorphine-Induced Growth Hormone Secretion

12 August 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy

12 August 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Diagnostic Criteria for Use in Psychiatric Research

12 August 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Biosynthesis of Human Growth Hormone and Prolactin

12 August 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Dextroamphetamine. Evaluation of psychomimetic properties in man

12 August 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Cocaine psychoses: a continuum model

12 August 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Clinical studies with dopamine-receptor stimulants

12 August 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

12 August 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Effect of cocaine on the disposition of noradrenaline labelled with tritium.

12 August 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Evidence for a new type of dopamine receptor stimulating agent.

12 August 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Enhancement of noradrenaline turnover in rat brain by L-dopa

12 August 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics

12 August 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

12 August 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

12 August 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Central noradrenergic function in man: vanillylmandelic acid in CSF

12 August 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

12 August 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Schizophrenia: elevated cerebrospinal fluid norepinephrine

12 August 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations

12 August 2023

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

12 August 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Brain Norepinephrine and Dopamine in Schizophrenia

12 August 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Dopamine-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients

12 August 2023

45

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Dopamine β-Hydroxylase Activity in Brains of Chronic Schizophrenic Patients

12 August 2023

46

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

The activities of brain dopamine-?-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls

12 August 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Dopamine beta-hydroxylase in CSF. Relationship to personality measures.

12 August 2023

49

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Disulfiram (Antabuse) Psychosis

12 August 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man

12 August 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenaline

12 August 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Evidence for a central postsynaptic action of clonidine

12 August 2023

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

12 August 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

12 August 2023

Biological Psychiatry

59

15

45

Jimerson D C

1980

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Communications in psychopharmacology

12 August 2023

61

4

507

Elizur A

1980

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Pharmacomanometric Studies of Colonic Motility as a Guide to the Chemotherapy of Schizophrenia

12 August 2023

62

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

American Journal of Psychiatry

12 August 2023

63

138

390

Lechin F

1981

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Communications in psychopharmacology

12 August 2023

64

4

477

Kafka M S

1980

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia

12 August 2023

65

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1983.TB06985.X

12 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6137940%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference